ForMyGluco
BlogGlossary← Home

What medicines do

How do GLP-1 injections differ from one another?

· 2 min

Two white electrical switches set into a single brushed metal plate on a pale wall; there is no writing or number on them.

Not every injected medicine used in diabetes is insulin; some stand in for a hormone the gut releases after a meal. This family is not one piece either. Its members differ by how they are given and which receiver they bind on the cell, not by the name on the box.

What the family shares is this: it stands in for a hormone the gut releases after a meal. That hormone ties the pancreas’s insulin release to the meal, slows stomach emptying and stretches fullness. Where the family touches the body is covered by “In how many groups are diabetes medicines divided?”. The question here is narrower.

The first split is visible. Most of the family is given under the skin, while one member also has a form taken by mouth. This is not just a difference of box; absorption conditions differ, so comparison studies measure the two forms separately.

The second split cannot be seen. Cell surfaces carry receivers that recognise these hormones, that is, receptors. Most of the family binds one receptor while one member binds two: the GLP-1 receptor and that of a second meal hormone called GIP. Its active substance is tirzepatide, and double binding gives a different answer.

The third difference shows up at the pharmacy and is not really one: the same active substance is sold under other names from country to country. The large name on the box is the brand. The medicine’s own name stands under it in small letters, and that second one serves when keeping a record.

Are these injections insulin?
They are not. Insulin steps straight into the place of what is missing; this family stands in for a hormone released after a meal and ties the pancreas’s own release to it.
Is the form taken by mouth the same as the injection?
The active substance is the same, the absorption conditions are not. That is why comparison studies measure the two forms separately and report their results separately.
Why is the member binding two receptors named apart?
Because alongside the GLP-1 receptor it also binds the GIP receptor; the answer measured differs from members binding one receptor.

Which member suits whom is not tied to one measure. The kidney and heart picture, weight, other medicines and daily routine are weighed together. That weighing is best done with a doctor.

Sources

  1. Collins L, Costello RA. Glucagon-Like Peptide-1 Receptor Agonists. [Updated 2024 Feb 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026.
  2. Zhou Q, Lei X, Fu S, et al. Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetology & Metabolic Syndrome. 2023;15:222. doi:10.1186/s13098-023-01198-4
  3. Karedath J, Nall S, Kaur M, et al. Comparative Effectiveness and Safety of Oral Versus Subcutaneous Semaglutide in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Cureus. 2025;17(4):e82497. doi:10.7759/cureus.82497
  4. American Diabetes Association Professional Practice Committee. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S183–S215. doi:10.2337/dc26-S009
  5. World Health Organization. WHO updates list of essential medicines to include key cancer, diabetes treatments. Geneva: World Health Organization; 5 September 2025.
  6. Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD). Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu-2026. 17. Baskı. TEMD; 2026. ISBN 978-625-99759-8-6

This piece is for information only; it is not a diagnosis, treatment or dosing recommendation. Always make decisions about your treatment together with your doctor.

Start keeping your own record

ForMyGluco keeps your readings, medications and appointments in one place, and prepares a doctor-ready PDF in a single tap.

View on the App Store →

All of the blog